Exchange
Xetra
Every company in the roster listed on Xetra.
Research
Compare financial metrics on this exchange
Research adds market cap, cash, runway and annualized R&D metrics with metric-specific sorting.
Views
4 of 4 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 BayerBAYN · Xetra | 15 assets: 5 approved, 5 Ph 3, 3 Ph 2, 2 Ph 1 | RiociguatPhase 3 · HypertensionReliable signal | 7 Oct 2026BAY3283142 · Phase 1 |
 Fresenius SE & Co. KGaAFRE · Xetra | 2 assets: 2 approved | Approved assets only | None on record |
 Formycon AGFYB · Xetra | 1 asset: 1 approved | Approved assets only | None on record |
 Heidelberg Pharma AGHPHA · Xetra | 1 asset: 1 Ph 2 | Pamlectabart tismanitinPhase 1/2 · Multiple Myeloma | Mar 2028Pamlectabart tismanitin · Phase 1/2 |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).